Credit Suisse’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-315,046
| Closed | -$5.53M | – | 3795 |
|
|
2021
Q3 | $5.53M | Buy |
315,046
+247,234
| +365% | +$4.34M | ﹤0.01% | 1462 |
|
|
2021
Q2 | $658K | Sell |
67,812
-18,929
| -22% | -$184K | ﹤0.01% | 2867 |
|
|
2021
Q1 | $932K | Buy |
86,741
+16,842
| +24% | +$181K | ﹤0.01% | 2618 |
|
|
2020
Q4 | $1.03M | Buy |
+69,899
| New | +$1.03M | ﹤0.01% | 2560 |
|
|
2017
Q1 | – | Sell |
-25,382
| Closed | -$143K | – | 3683 |
|
|
2016
Q4 | $143K | Buy |
+25,382
| New | +$143K | ﹤0.01% | 3527 |
|